Policy & Regulation
13 September 2019 - - German protein drug conjugates developer Tubulis and Glycotope, a clinical-stage immuno-oncology company, have signed a research and feasibility agreement, providing Glycotope ac...
13 September 2019 - It was reported yesterday that Castle Creek Pharmaceutical Holdings, Inc, a privately held holding company that holds and invests in companies in the orphan dermatology space, has ...
13 September 2019 - Switzerland-based Roche's lung cancer drug Tecentriq (atezolizumab) has improved overall survival rate in a phase III IMpower110 study, it was reported yesterday.The trial is ...
13 September 2019 - United States-based VBI Vaccines has collaborated with United Kingdom-based GlaxoSmithKline to clinically assess the combination of VBI-1901, VBI's cancer vaccine immunotherap...
12 September 2019 - It was reported yesterday that Biosortia, a drug discovery company focused on natural microbiomes, has named Dr John Ryals as its new Director.The new Director is the founder of Me...
Related Headlines